Who’s In Control? Thoratec, Investigators Discuss Access To NIH-Funded Data
This article was originally published in The Gray Sheet
Executive Summary
Thoratec is in negotiations with NIH to restrict access to control group data from the REMATCH randomized trial of the HeartMate VE upon the study's completion